Revalesio Corp
Pharmaceutical company · Tacoma, Washington, United States
Revalesio Corp is a pharmaceutical company headquartered in Tacoma, Washington, United States. It has reported private securities offerings to the US SEC, most recently $39 million sold in a notice filed in 2025.
Profile compiled from public records. Is this your company? Request a correction or update
Revalesio at a glance
Typepharmaceutical company
HeadquartersTacoma, Washington, United States
SEC CIK1552377
What does Revalesio do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $38.9 million sold (2025).
Frequently asked questions about Revalesio
Where is Revalesio headquartered?
Revalesio Corp is headquartered in Tacoma, Washington, United States.
What does Revalesio do?
Revalesio Corp is a pharmaceutical company.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences